186 related articles for article (PubMed ID: 37544475)
1. Human gamma-delta (γδ) T cell therapy for glioblastoma: A novel alternative to overcome challenges of adoptive immune cell therapy.
Choi H; Kim TG; Jeun SS; Ahn S
Cancer Lett; 2023 Sep; 571():216335. PubMed ID: 37544475
[TBL] [Abstract][Full Text] [Related]
2. Gammadelta T cells as immune effectors against high-grade gliomas.
Lamb LS
Immunol Res; 2009; 45(1):85-95. PubMed ID: 19711198
[TBL] [Abstract][Full Text] [Related]
3. γδ T cells as a potential therapeutic agent for glioblastoma.
Kang I; Kim Y; Lee HK
Front Immunol; 2023; 14():1273986. PubMed ID: 37928546
[TBL] [Abstract][Full Text] [Related]
4. The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation.
Pereboeva L; Harkins L; Wong S; Lamb LS
Cancer Immunol Immunother; 2015 May; 64(5):551-62. PubMed ID: 25676710
[TBL] [Abstract][Full Text] [Related]
5. Rapid alphabeta TCR-mediated responses in gammadelta T cells transduced with cancer-specific TCR genes.
Hiasa A; Nishikawa H; Hirayama M; Kitano S; Okamoto S; Chono H; Yu SS; Mineno J; Tanaka Y; Minato N; Kato I; Shiku H
Gene Ther; 2009 May; 16(5):620-8. PubMed ID: 19242528
[TBL] [Abstract][Full Text] [Related]
6. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
[TBL] [Abstract][Full Text] [Related]
7. Gamma/delta T cells as cellular vehicles for anti-tumor immunity.
Wang CQ; Lim PY; Tan AH
Front Immunol; 2023; 14():1282758. PubMed ID: 38274800
[TBL] [Abstract][Full Text] [Related]
8. γδ T Cell-Based Adoptive Cell Therapies Against Solid Epithelial Tumors.
Bustos X; Snedal S; Tordesillas L; Pelle E; Abate-Daga D
Cancer J; 2022 Jul-Aug 01; 28(4):270-277. PubMed ID: 35880936
[TBL] [Abstract][Full Text] [Related]
9. γδ T-cell immunotherapy for lung cancer.
Yoshida Y; Nakajima J; Wada H; Kakimi K
Surg Today; 2011 May; 41(5):606-11. PubMed ID: 21533930
[TBL] [Abstract][Full Text] [Related]
10. Human allogenic γδ T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands.
Choi H; Lee Y; Park SA; Lee JH; Park J; Park JH; Lee HK; Kim TG; Jeun SS; Ahn S
Oncoimmunology; 2022; 11(1):2138152. PubMed ID: 36338147
[TBL] [Abstract][Full Text] [Related]
11. Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy.
Lamb LS; Bowersock J; Dasgupta A; Gillespie GY; Su Y; Johnson A; Spencer HT
PLoS One; 2013; 8(1):e51805. PubMed ID: 23326319
[TBL] [Abstract][Full Text] [Related]
12. Perspectives of gammadelta T cells in tumor immunology.
Kabelitz D; Wesch D; He W
Cancer Res; 2007 Jan; 67(1):5-8. PubMed ID: 17210676
[TBL] [Abstract][Full Text] [Related]
13. A close look at current γδ T-cell immunotherapy.
Ma L; Feng Y; Zhou Z
Front Immunol; 2023; 14():1140623. PubMed ID: 37063836
[TBL] [Abstract][Full Text] [Related]
14. Potential of human γδ T cells for immunotherapy of osteosarcoma.
Li Z
Mol Biol Rep; 2013 Jan; 40(1):427-37. PubMed ID: 23065272
[TBL] [Abstract][Full Text] [Related]
15. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
Li Y; Li G; Zhang J; Wu X; Chen X
Front Immunol; 2020; 11():619954. PubMed ID: 33664732
[TBL] [Abstract][Full Text] [Related]
16. Patterns of chemokine receptor expression on peripheral blood gamma delta T lymphocytes: strong expression of CCR5 is a selective feature of V delta 2/V gamma 9 gamma delta T cells.
Glatzel A; Wesch D; Schiemann F; Brandt E; Janssen O; Kabelitz D
J Immunol; 2002 May; 168(10):4920-9. PubMed ID: 11994442
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Glioblastoma: Adoptive T-cell Strategies.
Choi BD; Maus MV; June CH; Sampson JH
Clin Cancer Res; 2019 Apr; 25(7):2042-2048. PubMed ID: 30446589
[TBL] [Abstract][Full Text] [Related]
18. Gammadelta T cells assist alphabeta T cells in the adoptive transfer of contact hypersensitivity to para-phenylenediamine.
Yokozeki H; Watanabe K; Igawa K; Miyazaki Y; Katayama I; Nishioka K
Clin Exp Immunol; 2001 Sep; 125(3):351-9. PubMed ID: 11531941
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic avenues for γδ T cells in cancer.
Costa GP; Mensurado S; Silva-Santos B
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38007241
[TBL] [Abstract][Full Text] [Related]
20. gammadelta T cells in cancer immunotherapy: current status and future prospects.
Chiplunkar S; Dhar S; Wesch D; Kabelitz D
Immunotherapy; 2009 Jul; 1(4):663-78. PubMed ID: 20635991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
